Lista de obras - Li Huang - Dominio Público Uruguay

Activation and inhibition of the proteasome by betulinic acid and its derivatives

artículo científico publicado en 2007

Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents.

artículo científico publicado en 2010

Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors

artículo científico publicado en 2010

Anti-AIDS agents 85. Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents.

artículo científico publicado en 2011

Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.

artículo científico publicado en 2012

Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents

artículo científico publicado en 2009

Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.

artículo científico publicado en 2007

Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.

artículo científico publicado en 2004

Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564.

artículo científico publicado en 2004

Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors

artículo científico publicado en 2012

Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.

artículo científico publicado en 2012

Discovery of novel 5-fluoro-N(2),N(4)-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9.

artículo científico publicado en 2015

Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome

artículo científico publicado en 2015

Identification and synthesis of quinolizidines with anti-influenza a virus activity

artículo científico publicado en 2014

Induction of a nonproductive conformational change in gp120 by a small molecule HIV type 1 entry inhibitor

scientific article published on 01 January 2007

Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles

artículo científico publicado en 2005

Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives.

artículo científico publicado en 2005

New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.

artículo científico publicado en 2013

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors

artículo científico publicado en 2012

Optimization of the antiviral potency and lipophilicity of halogenated 2,6-diarylpyridinamines as a novel class of HIV-1 NNRTIS.

artículo científico publicado en 2014

Phenolic diterpenoid derivatives as anti-influenza a virus agents

artículo científico publicado en 2015

Picomolar dichotomous activity of gnidimacrin against HIV-1.

artículo científico publicado en 2011

Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41.

artículo científico publicado en 2003

Proteasome regulators: activators and inhibitors.

artículo científico publicado en 2009

Structure of a tethered cationic 3-aminopropyl chain incorporated into an oligodeoxynucleotide: evidence for 3'-orientation in the major groove accompanied by DNA bending

artículo científico publicado en 2002

Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides

artículo científico publicado en 1994

Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives

artículo científico publicado en 2005

Synthesis and proteasome inhibition of lithocholic acid derivatives

artículo científico publicado en 2011

Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants

artículo científico publicado en 2012

Lista de obras de Li Huang

Activation and inhibition of the proteasome by betulinic acid and its derivatives

Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents.

Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors

Anti-AIDS agents 85. Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents.

Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors.

Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents

Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.

Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.

Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564.

Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors

Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.

Discovery of novel 5-fluoro-N(2),N(4)-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9.

Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome

Identification and synthesis of quinolizidines with anti-influenza a virus activity

Induction of a nonproductive conformational change in gp120 by a small molecule HIV type 1 entry inhibitor

Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles

Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives.

New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors

Optimization of the antiviral potency and lipophilicity of halogenated 2,6-diarylpyridinamines as a novel class of HIV-1 NNRTIS.

Phenolic diterpenoid derivatives as anti-influenza a virus agents

Picomolar dichotomous activity of gnidimacrin against HIV-1.

Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41.

Proteasome regulators: activators and inhibitors.

Structure of a tethered cationic 3-aminopropyl chain incorporated into an oligodeoxynucleotide: evidence for 3'-orientation in the major groove accompanied by DNA bending

Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides

Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives

Synthesis and proteasome inhibition of lithocholic acid derivatives

Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants